AFP DEPARTMENT COLLECTION

POEMs: Patient-Oriented Evidence that Matters

POEMs (Patient-Oriented Evidence that Matters) are summaries of research that is relevant to physicians and their patients and meet three criteria: address a question that primary care physicians face in day-to-day practice; measure outcomes important to physicians and patients, including symptoms, morbidity, quality of life, and mortality; and have the potential to change the way physicians practice.

Oct 15, 2020 Issue
C-Reactive Protein Is the Most Useful Biomarker for Diagnosis of Outpatient CAP
This review found that the best evidence supports C-reactive protein as the most useful and accurate biomarker for diagnosing CAP in adults presenting with lower respiratory tract symptoms.


Oct 15, 2020 Issue
Increased Daily Steps Associated with Reduced All-Cause Mortality
This study found that a greater number of daily steps was significantly associated with lower all-cause mortality.


Oct 15, 2020 Issue
Terbinafine and Itraconazole Are Most Effective for Toenail Onychomycosis
For toenail onychomycosis, continuous terbinafine (Lamisil), 250 mg, and continuous itraconazole (Sporanox), 200 mg, for 12 to 24 weeks are the preferred therapies.


Oct 15, 2020 Issue
Cycled Hyperbaric Oxygen Improves the Healing of Diabetic Foot Ulcers
Hyperbaric oxygen provided with a device that cycles oxygen from high pressure to low pressure increased the likelihood of complete healing of diabetic foot ulcers when combined with standard dressing and an offloading boot.


Sep 15, 2020 Issue
Fecal Microbiota Transplant Effective for Irritable Bowel Syndrome
This is the largest and best study to date of fecal microbiota transplant for irritable bowel syndrome —with impressive results.


Sep 15, 2020 Issue
ACR Guideline for Managing Patients with Degenerative Joint Disease of the Hand, Knee, and Hip
This meta-analysis found no evidence that the monoclonal antibody denosumab reduces the risk of fracture more than bisphosphonates.


Sep 15, 2020 Issue
Similar Long-Term Morbidity and Mortality with Human Insulin and Analogue Insulin
This study found no difference in long-term patient-oriented outcomes between human and analogue insulins in adults with type 2 diabetes.


Sep 15, 2020 Issue
Denosumab No Better than Bisphosphonates for Preventing Fracture, and the Cost Is Much Higher
This meta-analysis found no evidence that the monoclonal antibody denosumab reduces the risk of fracture more than bisphosphonates.


Aug 15, 2020 Issue
Daily Colchicine Post-MI Reduces Strokes and Recurrent Hospitalizations for Angina
Daily colchicine after MI reduces cardiovascular events, specifically strokes and hospitalizations for angina. It is inexpensive and well-tolerated and should be considered for patients with recent MIs who are already using guideline-directed therapy.


Aug 15, 2020 Issue
Small Reduction in Cardiovascular Outcome After Ischemic Stroke with Lower LDL Target, but also Harms; No Change in All-Cause Mortality
A lower LDL target slightly reduced the likelihood of a broad composite outcome (number needed to treat [NNT] = 43 over 3.5 years), largely by reducing nonfatal strokes (NNT = 77; statistical significance not reported).


Pages: 1 2 3 4 5 6 7 8 9 10 ... 37 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now